Drug Repurposing for Type 2 Diabetes Using Combined Textual and Structural Graph Representation Based on Transformer

N/ACitations
Citations of this article
21Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Type 2 diabetes has been predominant for years. There is still no cure to help patients completely recover from the sickness. Drug repurposing can help to discover a new drug by repositioning existing drugs for new medications. Prior attempts, however, to resolve this issue are found to be limited. Performance relied on a single representation without any improvement being achieved. To surmount this task, a deep learning approach is applied. Link prediction using graph neural networks is used. Our model's architecture is based on a 'transformer': a recent and popular deep learning network. For our link prediction in the graph, each entity is embedded by using both: (1) structural information sourced from a node and its neighbor's nodes, and (2) semantic information extracted from its name and description. The experiment is conducted via type 2 diabetes data that we extracted and prepared from PubMed and UMLS Metathesaurus. Results demonstrate that our combined model, by showing an increase of 77.17% on the mean reciprocal rank (MRR) score for the drug discovery task, can outperform other models that only have a single module i.e. StAR and HittER. Finally, after deploying the model for drug repurposing, we can discover some drugs that have the potential to be used for type 2 diabetes treatment.

Cite

CITATION STYLE

APA

Mam, S., Wichadakul, D., & Vateekul, P. (2023). Drug Repurposing for Type 2 Diabetes Using Combined Textual and Structural Graph Representation Based on Transformer. IEEE Access, 11, 65711–65724. https://doi.org/10.1109/ACCESS.2023.3289863

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free